Paul Mampilly is a notable investor and former hedge fund manager with over 30 years of experience in the investment industry. He is the Founder of the popular investment newsletter Profits Unlimited, where he uses his skills, experience, and knowledge as a former Wall Street insider to guide his more than 130,000 subscribers into stocks that are primed to shoot higher. He has developed a knack for identifying the most prominent trends in the market, even before they become mainstream. Today, he serves as the Founder of ATG Digital Media, a community-driven enterprise that makes financial freedom accessible to everyday people. He is also a regular contributor to seminars, conferences, and websites featuring cutting-edge market analysis and commentary.
He was an author for Agora Financial's premier biotechnology and life science franchise, FDA Trader.
FDA Trader generated over $6 million in sales during his tenure. FDA was also the #1 source for independently published biotech investment research for investors.
He was an author for The Professional Speculator, a stock advisory service published by Stansberry Research focused on speculative stocks.
EARLY CAREER
He started his career as an Assistant Portfolio Manager at Bankers Trust, where he managed high net worth private client portfolios.
He served as a Research Analyst at Deutsche Bank and a Senior Research Analyst at ING.
He oversaw the Royal Bank of Scotland account and Kinetics Wealth Management LLC, a $6 billion hedge fund.
He won first place in a prominent investing competition due to his vast background as a hedge fund trader.
With an initial investment of $50 million, he obtained a return of 76%. Most importantly, it happened during the financial crisis of 2008 and 2009.
NEWSLETTERS
True Momentum
Paul Mampilly's Inner Circle
Paul's Secret Portfolio
MEDIA & PUBLICATIONS
His articles have appeared in Investor’s Business Daily, Forbes, Yahoo! Finance, Businessweek, and several others.
He is also a featured contributor for the free newsletter, Bold Profits Daily, America’s No. 1 source for growth investing.
He is well known in the sphere of stockholders because of his immense success in projects such as The $10 Million Portfolio.